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Data from the Encyclopedia of DNA Elements (ENCODE) project show over 9640 human genome loci classified as long
noncoding RNAs (lncRNAs), yet only ~100 have been deeply characterized to determine their role in the cell. To measure
the protein-coding output from these RNAs, we jointly analyzed two recent data sets produced in the ENCODE project:
tandem mass spectrometry (MS/MS) data mapping expressed peptides to their encoding genomic loci, and RNA-seq data
generated by ENCODE in long polyA+ and polyA– fractions in the cell lines K562 and GM12878. We used the machinelearning algorithm RuleFit3 to regress the peptide data against RNA expression data. The most important covariate for
predicting translation was, surprisingly, the Cytosol polyA– fraction in both cell lines. LncRNAs are ~13-fold less likely to
produce detectable peptides than similar mRNAs, indicating that ~92% of GENCODE v7 lncRNAs are not translated in
these two ENCODE cell lines. Intersecting 9640 lncRNA loci with 79,333 peptides yielded 85 unique peptides matching 69
lncRNAs. Most cases were due to a coding transcript misannotated as lncRNA. Two exceptions were an unprocessed
pseudogene and a bona fide lncRNA gene, both with open reading frames (ORFs) compromised by upstream stop codons.
All potentially translatable lncRNA ORFs had only a single peptide match, indicating low protein abundance and/or
false-positive peptide matches. We conclude that with very few exceptions, ribosomes are able to distinguish coding from
noncoding transcripts and, hence, that ectopic translation and cryptic mRNAs are rare in the human lncRNAome.
[Supplemental material is available for this article.]
In addition to over 20,000 protein-coding genes and known
small-RNA, including microRNA host genes, the human genome
includes at least 9640 loci transcribed solely into long, nonprotein-coding RNAs (long noncoding RNAs; lncRNAs), often
with multiple transcript isoforms (Derrien et al. 2012). Of these,
only a minority (under 100) have been functionally characterized
at an individual level by forward and reverse genetic approaches in
organismal and cell culture models. The remainder are known
purely via high-throughput discovery and expression analysis.
Well-known examples of lncRNAs that have been functionally
characterized in-depth include the imprinted Myc target H19
(Gabory et al. 2009), the epigenetic homeobox gene regulator
HOTAIR, which promotes cancer metastasis (Gupta et al. 2010),
and Xist, the lncRNA that is responsible for inactivation of the
mammalian X-chromosome ( Jeon and Lee 2011). While these
few examples already attest to the diversity of lncRNA functions in chromatin remodeling and imprinting, the diversity of
heretofore-uncharacterized lncRNAs hints at numerous additional
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lncRNA-dependent regulatory mechanisms in mammalian systems. Miat is another example of a recently discovered lncRNA
that takes part in a direct network feedback loop with the Pou5f1
pluripotency factor in stem cells (Pou5f1 is also known as Oct4);
Miat is both a direct target of and a direct regulator of Pou5f1
(Lipovich et al. 2010; Sheik Mohamed et al. 2010). Hence, lncRNAs
can be both regulated by and regulators of key transcription factors. LncRNA genes are transcribed in a diverse range of human
tissues and cell lines, and show highly specific spatial and temporal expression profiles, which, in conjunction with detailed
molecular characterization of the lncRNAs, attest to numerous
distinct functions. These functions include, but are not limited
to, epigenetic and post-transcriptional gene expression regulation, sense-antisense interactions with known protein-coding
genes, direct binding and regulation of transcription factor proteins, nuclear pore gatekeeping, and enhancer function by transcriptional initiation of lncRNAs that cause chromatin remodeling (Lipovich et al. 2010). Mammalian lncRNAs have epigenetic
signatures comparable to those of protein-coding genes, frequently associate with the polycomb repressor complex PRC2
which renders them capable of regulating numerous target genes
through histone modifications suppressing gene expression, and
mediate global transcriptional programs of cancer transcription
factors (Guttman et al. 2009; Khalil et al. 2009; Huarte et al. 2010;
Derrien et al. 2012).
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LncRNAs are rarely translated
A particularly intriguing property of mammalian lncRNAs is
their lack of evolutionary conservation, relative to protein-coding
genes. Primate-specific lncRNAs in the human genome are increasingly well-documented in the literature (for a review citing
multiple pertinent recent reports, see Lipovich et al. 2010). Previously, Tay et al. (2009) screened the human genome for primatespecific single-copy genomic sequences, uncovering 131 primatespecific transcriptional units supported by transcriptome data. The
brain-derived neurotrophic factor (BDNF ) gene, a key contributor
to synaptic plasticity, learning, memory, and multiple neurological
diseases, is overlapped by a cis-encoded primate-specific lncRNA
(Pruunsild et al. 2007). Most recently, Derrien et al. (2012) found
that ;30% of human lncRNA transcripts in GENCODE, many of
which are expressed in the brain, are primate specific. The resulting
relevance of lncRNAs to species-specific phenotypes, including
primate and human uniqueness, highlights the importance of
using empirical methodologies to document whether lncRNAs
are actually non-protein-coding.
The majority of definitively known lncRNAs have been annotated using empirical evidence such as cDNA and EST alignments to genome assemblies (Carninci et al. 2005; Katayama et al.
2005; Affymetrix/Cold Spring Harbor Laboratory ENCODE Transcriptome Project 2009). Yet, despite the attention that they have
received, the noncoding status of most lncRNA genes and transcripts has been established mostly through computational means
including: examining the size of open reading frames (ORFs),
assessing conservation of ORFs that are shorter than known proteins, and looking for conserved translation initiation and termination codons. However, a recent flurry of literature suggests that
there may exist a class of bifunctional RNAs encoding both mRNAs
and functional noncoding transcripts: Indeed, there is direct evidence for rare members of this transcript class in human, mouse,
and fly (Hube et al. 2006; Kondo et al. 2010; Dinger et al. 2011;
Ingolia et al. 2011; Ulveling et al. 2011). Hence, identifying the
fraction of ostensibly noncoding RNAs that may encode polypeptides is a compelling and open question. In this report, we
utilize empirical evidence to estimate, in two ENCODE cell lines,
the fraction of annotated lncRNAs that may encode, and therefore possibly function through, polypeptides.
As part of the Encyclopedia of DNA Elements (ENCODE)
project, matched-sample long polyA+ and polyA RNA-seq data
were produced, along with tandem mass spectrometry (MS/MS)
data for cellular proteins, for the Tier-1 ‘‘ENCODE-prioritized’’
human cell lines K562 and GM12878. The RNA-seq data provides
measures of relative gene expression in various cellular compartments (Djebali et al. 2012); for both GM12878 and K562, nucleus,
cytosol, and whole-cell samples were used to sequence both polyA+
and polyA RNA populations. These data have been used to obtain
measures of transcript abundance for all genes in GENCODE v7
annotation (the annotation generated for the ENCODE Consortium), based on ENCODE and other data (Harrow et al. 2012). The
mass spec data were produced via a ‘‘shotgun’’ approach, wherein
cells were cultured, subcellular fractionation performed, followed
by protein separations, tryptic digestion, and MS/MS analysis. The
resulting spectra were mapped directly to a 6-frame translation of
the entire hg19 assembly to produce a ‘‘proteogenomic track’’
within the UCSC Genome Browser (Kent 2002; Karolchik et al.
2009), and were also mapped against the GENCODE gene annotation set ( J Khatun, Y Yu, J Wrobel, BA Risk, HP Gunawardena,
A Secrest, WJ Spitzer, L Xie, L Wang, X Chen, et al., in prep.). Integrative analysis of RNA and proteomics data has been explored
in the literature and is examined in another ENCODE paper,

highlighting translation of novel splice variants and expressed
pseudogenes (Tian et al. 2004, Djebali et al. 2012). However, these
data have not yet been applied to examine the empirical evidence
for or against translation of computationally classified human
long noncoding RNAs. A recent joint study of RNA and proteomic
data in mouse revealed that protein levels and mRNA levels correlate such that RNA concentration is predictive of at least 40% of
the variation in protein levels (Schwanhäusser et al. 2011). Since
lncRNA genes are expressed, on average, at 4% of the level of
protein-coding genes in the ENCODE cell lines (Derrien et al.
2012), we expect a similarly low level of expression for any putative
protein(s) translated from lncRNAs. Therefore, to interrogate the
translational competence of lncRNAs, we must account for the
relative expression levels of these transcripts.
It has been shown that the quantity of detectable matches between MS/MS spectra and their corresponding peptides in a transcript
correlate to protein abundance levels (Lu et al. 2007). This means that
the number of detected peptide matches is an approximate surrogate
for protein abundance (Liu et al. 2004; Vogel and Marcotte 2008). We
used this characteristic to determine a calibration function that links
mRNA expression abundance and protein expression abundance for
the ENCODE data from K562 and GM12878. In our analysis, 21% of
GENCODE v7 protein-coding genes are represented by at least one
uniquely mapping peptide in any MS/MS sample, and the majority of
those genes detected are expressed above 5 RPKMs in the wholecell RNA-seq data (Harrow et al. 2012). We used these data, applying
state-of-the-art machine-learning models to estimate the translational competence of transcripts as a function of RNA expression
levels in various cellular compartments and RNA fractions. Using
these models, we ‘‘regressed out’’ the expression-level effects to
compare the translation competency of ostensibly noncoding
transcripts to that of known mRNAs. We then manually examined
each lncRNA for which we obtained empirical evidence of coding
capacity. From these data, we determined the proportion of lncRNAs
that appear to be truly ‘‘noncoding’’ in ENCODE Tier 1 cell lines,
and we examined the exceptional cases where there was strong
evidence of protein translation to determine whether these are
indeed translated lncRNAs or simply misannotated mRNAs.

Results
The ENCODE Consortium has generated tandem mass spectrometry (MS/MS) data for the Tier-I ENCODE cell lines. This data has
been mapped to the UCSC hg19 assembly in order to identify the
best-fit genomic locus for each mass spectrum. The data comprised
those peptides mapping within an estimated #10% FDR, based on
decoy database searches. (See J Khatun, Y Yu, J Wrobel, BA Risk, HP
Gunawardena, A Secrest, WJ Spitzer, L Xie, L Wang, X Chen, et al.,
in prep. for a detailed discussion of the proteogenomics data and
mapping strategies.) Here, we further filtered the set to consider
only peptides that mapped to unique genomic locations (i.e., unique
peptide sequences). We queried each unique genomic peptide location for same-strand overlap with any exons of any of the 15,512
GENCODE lncRNA transcripts, all of which have been inferred from
experimental (full-length clones or stranded RNA-seq) transcriptome
data, and which summarily correspond to 9640 lncRNA genes.
Out of 350 distinct locations in which lncRNA-matching
peptides were detected, there were 85 that uniquely mapped to
exons of 111 GENCODE v7 lncRNA transcripts and nowhere else
in any ORF in the human genome (see Methods). The 111 lncRNA
transcripts are assignable to 69 distinct loci (GENCODE v7 genes)
in the human genome. Of these uniquely mapping peptides, 26
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peptides (from 10 loci) were ‘‘non-singleton hits,’’ in that either
more than one peptide was detected mapping in-frame to the
same lncRNA, or the same peptide was independently detected
multiple times in independent MS/MS assays. The remaining 59
were singletons, detected only one time and in only one sample.
We consider singleton hits to be potential evidence, but not confirmation of translation, and we consider only the non-singletons to
correspond to detected instances of translation. This standard of at
least technical replication is consistent with the data standards of the
ENCODE Consortium (The ENCODE Project Consortium 2012).

RNA expression levels are correlated with the detectability
of peptides in ENCODE MS/MS and RNA-seq data
The MS/MS data generated by the ENCODE Consortium is nonquantitative, in the sense that the MS/MS protocol seeks only to
detect the presence or absence of peptides, and does not attempt
quantification of relative or absolute peptide levels ( J Khatun, Y Yu,
J Wrobel, BA Risk, HP Gunawardena, A Secrest, WJ Spitzer, L Xie, L
Wang, X Chen, et al., in prep.). It was not clear a priori that previous results reporting the predictability of quantitative MS/MS
data from mRNA levels would relate directly to this mode of MS/
MS (Schwanhäusser et al. 2011). Furthermore, the RNA data collected by the ENCODE Consortium includes polyA6 fractions in
K562 and GM12878 nucleus, cytosol, and whole-cell samples, as
well as total RNA in K562 nucleolus, nucleoplasm, and a sample
purified from extracted chromatin, all in replicate, and all sequenced to a depth of more than 20 million reads (Djebali et al.
2012). In whole-cell RNA-seq data, lncRNA expression levels are on
average 24-fold lower than mRNAs in polyA+ long RNA data, and
20-fold lower in polyA long RNA-seq data. Figure 1, A and B shows
that whole-cell RNA levels correlate with the rate of peptide detection (rank correlation, r ;0.41 on average) (see also Table 1 and
Supplemental Figs. 1, 2). Hence, it is clear that in order to understand the translational competency of RNAs, it is essential to
normalize for expression level. Our ability to conduct this normalization is greatly enhanced by the richness of the RNA-seq data, with
which we are able to study how differential RNA concentrations
across cellular compartments and RNA fractions relate to the detectability of individual peptides by MS/MS.

Lowly expressed RNAs rarely produce detectable peptides
Table 1 and Figure 1 illustrate that lowly expressed RNAs produce
few detectable peptides. Hence, the marginal effect of increased
expression levels in any given fraction is an increase in the likelihood that at least one peptide will be detected in MS/MS. However,
there may also be complex joint effects between the various
measurements, e.g., a marginal increase in polyA nuclear transcription coupled with a decrease in polyA+ cytosol transcription
may actually decrease the likelihood of peptide detection. To directly model these joint effects, we utilized a machine-learning
algorithm based on Random Forests that incorporates both boosting
and model-selection procedures to produce sparse, and therefore
robust and interpretable classification models known as RuleFit3
(Friedman and Popescu 2008; see Methods for details).

Long RNA relative expression levels across cellular
compartments and polyA+ and polyA fractions accurately
and robustly predict peptide detectability in MS/MS
We fit machine-learning models to the GM12878 and K562 data
independently and on independent sets of replicates of RNA-seq
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Figure 1. Expression levels are correlated with peptide detectability via
MS/MS. Peptide detectability (y-axis) as a function of RNA expression
levels (RPKM, x-axis) in GM12878 (A) and K562 (B) whole-cell RNA samples. We identified peptides for only 1% of genes expressed at RPKM <0.1,
whereas we detected peptides for ;40% of genes expressed above RPKM
100. In general, the likelihood of detection rises as expression level rises.

data in order to assess the reproducibility of our conclusions (see
Methods). Our classifiers distinguish between genes with at least
one uniquely mapping peptide and those with no uniquely
mapping peptides. We were able to construct models with misclassification rates of 21% in K562 and 23% in GM12878 computed on held-out test-sets in both cell lines and on either collection of independent replicates (see Methods). Furthermore,
when the models are trained on one set of replicates and tested on
the other, the average misclassification rate rises only slightly, to
22% in K562 and 25% in GM12878. Hence, our models are both
biologically and technically robust.
Because the cellular RNA fractions sequenced in RNA-seq by
ENCODE differ between the two cell lines, we had more information to build our predictor in K562 than in GM12878. In
order to assess the similarity of the imputed models in either cell
line, we fit a model in K562 that utilized only the compartments
available in GM12878 (six fractions: polyA6 in Cytosol, Nucleus,
and Whole Cell). We then evaluated the performance of the K562
model on the GM12878 data and vice versa. The probability of
misclassification increased modestly, from 25% within GM12878
and 22% within K562 to 26% for the GM12878 model tested on
K562 and 24% for the K562 model tested on GM12878. The failure
of the model to predict correctly in 21%–26% of the cases is not
surprising, since we would expect that, for at least some proteins,
transcript abundance is strongly dependent on the stability of the
mRNA transcript as well as protein degradation rates.

An expression pattern indicative of translational competence
The most important predictor in either cell line (in both the K562
full model and the model using only GM12878 available data), is
the polyA Cytosol RNA fraction, and the direction of dependence
is positive: higher polyA Cytosol RNA levels correspond to an
increased likelihood of detectable translation (Fig. 2; Supplemental
Fig. 3). Although there is some substantial reordering of covariate
importance down the rank-list, this has only a moderate effect on
model performance between the two cell lines and, indeed, the
precise order of covariates after polyA Cytosol was unstable in
K562 between biological replicates (see Supplemental Fig. 3). The
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The fraction of genes with detected peptides (see Methods) with RPKM expression levels in the above indicated ranges. The numbers in parentheses are the exact binomial confidence bounds of the
estimated portions. We note that, counterintuitively, in several samples a higher fraction of genes with high polyA expression are represented in the peptide data. However, this is due to the fact that
the polyA data is more diverse and samples a wider range of genes than the polyA+ data (Djebali et al. 2012); hence, there are far fewer genes with extremely high expression levels in the polyA
fractions. This is apparent from the binomial confidence bounds, which are correspondingly wider. Furthermore, these tend to be genes that are also highly expressed in the polyA+ fractions.

GM12878 Cytosol polyA+
GM12878 Cytosol polyA
GM12878 Whole Cell polyA+
GM12878 Whole Cell polyA
GM12878 Nucleus polyA+
GM12878 Nucleus polyA
K562 Cytosol total
K562 Cytosol polyA+
K562 Cytosol polyA
K562 Whole Cell total
K562 Whole Cell polyA+
K562 Whole Cell polyA
K562 Nucleoplasm total
K562 Chromatin total
K562 Nucleus total
K562 Nucleus polyA+
K562 Nucleus polyA
K562 Nucleolus total

[0.001,0.01]

Table 1. Fraction of genes detectable at various expression levels (in RPKMs)

LncRNAs are rarely translated
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Figure 2. Visualizing some of the properties of the model of RNA-seq and MS/MS data. (A,B) Relative importance of each of the covariates (RNA
fractions). (C ) Relative partial dependence of the likelihood of detecting at least one uniquely mapping peptide on the polyA+ Whole Cell and polyA
Cytosol fractions from GM12878. This is known as a ‘‘partial dependence plot.’’ We note that detectable polyA Cytosol expression is nearly a prerequisite
to detecting uniquely mapping peptides, even when polyA+ Whole Cell expression is extremely high. (D) Partial dependence plot for the total RNA
nucleolus and chromatin fractions from K562. (E,F ) ‘‘Interaction strength plots.’’ These show the relative importance of considering the dependence
between pairs of covariates (fractions) in the overall predictive model. (Red bars) Standard deviation under the null of no association.

usual interpretation of this sort of effect is colinearity between the
variables: The various RNA fractions appear to provide some redundant information.
We studied the joint effect of the various cellular RNA
fractions on our predictions (Fig. 2). In both cell lines, a number
of pairwise interactions between the compartments were statistically significant (Fig. 2E,F; Supplemental Fig. 4). Here a statistically significant interaction is defined to be an interaction
that is much stronger than would be expected if the expression
levels were independent (Methods). Note that this does not
mean that an interaction is important for predictive power. For
instance, one of the most statistically significant interactions in
K562 is total RNA Chromatin fraction with total RNA Nucleolus
fraction, but the effect of increasing RPKM in the Nucleolus
fraction is minimal (Fig. 2B,D,F): Very low values of expression
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in the Nucleolus imply a lack of detectable translation, and very high
values slightly decrease the likelihood of translation, except when
coupled with extremely high values in the Chromatin fraction.
The most stable interaction between both biological replicates and the two cell lines is observed between the polyA+ Whole
Cell fractions and the polyA Cytosol fractions in both cell lines
(Fig. 2E,F). High polyA+ Whole Cell expression levels generally
imply a high likelihood of detectable translation, except, interestingly, when little or no transcription is observed in the polyA
Cytosol fraction. The same dependence structure is observed between the polyA+ and polyA Cytosol fractions, although it is not
statistically significant in GM12878 ( P > 0.01, permutation test). In
contrast, neither the polyA+ nor polyA nuclear samples (including, in K562, the total RNA Nucleoplasm sample) showed significant interactions.

LncRNAs are rarely translated
An upper bound on the translational competency of lncRNAs
in ENCODE cell lines GM12878 and K562
To estimate the fraction of lncRNAs that are translated in vivo, we
compare the rate of detection of lncRNA translation with that for
mRNAs expressed at similar levels. This is necessary, because otherwise any conclusions about the translational competency of
lncRNAs would be subject to statistical confounding with levels
and patterns of transcription. By interrogating our predictive
models we can ‘‘regress out’’ transcriptional effects on the detectability of peptides (see Methods for details). For mRNAs with
expression levels comparable to those of lncRNAs in GM12878,
between 4.4% and 5.9% code for detected peptides (see Table 2).
These numbers are directly comparable to the 0.33% of lncRNAs
with detected translation in the same cell line ( P < 10 16, two-sided
x2 test). For K562 we have detected translation for between 1.5%
and 1.8% of mRNAs with lncRNA-consistent expression patterns
and 0.09% of lncRNAs ( P < 10 16, two-sided x2 test). Hence,
lncRNAs are likely between 13- and 20-fold depleted for detected
translation given their expression patterns. We can obtain an upper bound for the fraction of GENCODE v7 lncRNAs translated in
vivo by considering that we ‘‘should have detected’’ peptides corresponding to 100% of mRNAs. This is an upper bound because
clearly not all mRNAs are expressed in these cells, and hence
cannot produce peptides. Indeed, we have zero expression values
across all compartments for 5.5% of GENCODE v7 mRNAs in
GM12878 and 6.0% in K562, 7.1% are zero across all polyA+
samples in GM12878 and 9.2% in K562, and finally 60% are zero
in at least one compartment in GM12878 and 51% in K562. Under
the conservative model that all mRNAs were detectable, we infer
that at least 92% of GENCODE v7 lncRNAs are untranslated in
these cell lines.

The possibility of widespread translation of short polypeptides
We have demonstrated that lncRNAs are depleted for peptides that
are detectable in our tandem MS/MS assay, but it remains possible
that extremely short or rapidly degraded polypeptides exist that
have gone undetected. The length of ORFs is largely uncorrelated
with the number of peptides that we detected (r ;0.08, r ;0.005).
In Supplemental Figure 5A we see that ORFs with detected peptides
are enriched for long ORFs compared with the GENCODE v7 total
ORF set (KS-2-sample test P < 10 16), but see that this effect is
dominated by an enrichment for ORFs of more than 3K amino
acids, rather than by a depletion of short ORFs (Supplemental Fig.
5B). However, the shortest GENCODE v7 ORF for which we have
Table 2. lncRNAs are depleted more than 10-fold for detected
polypeptides
GENCODE v7
mRNA
mRNA
Cell Line

ALL

GM12878 20.50%
K562
15.10%

lncRNA

Depletion

p-value

lncRNA-like
expression

ALL

Fold change

x2

;5.15%
;1.65%

0.33%
0.09%

;15
;18

<1 3 10
<1 3 10

16
16

In both cell lines, lncRNAs are more than 10-fold depleted for detected
peptides compared with mRNAs expressed at similar levels across samples
(lncRNA-like expression patterns). The designation, ‘‘lncRNA-like expression patterns’’ comes from our RuleFit3 model of peptide data (modeled
as a function of RNA-seq data).

identified a peptide is 69 nucleotides, 23 amino acids; this implies
an empirical size limit on detectability for our current data. Hence,
it is possible that a population of short polypeptides has escaped
the detection limits of our current MS/MS assay. Although we
cannot rule out this possibility, we can provide an empirical
bound: If the translation of short ORFs into stable polypeptides is
widespread in the GENCODE v7 lncRNAs, then these likely encode
polypeptides shorter than ;23 amino acids in length.

Exhaustive manual reannotation of putatively
translated lncRNAs
We performed in-depth visual manual annotation of each peptide
uniquely mapping to a GENCODE v7 lncRNA by concurrent interpretation of the output from four tools: UCSC Genome Browser
(Karolchik et al. 2009), UCSC BLAT (Kent 2002), NCBI BL2SEQ
(Tatusova and Madden 1999) with TBLASTN functionality, and NCBI
ORF Finder (Wheeler et al. 2003) (see Supplemental Material). We
have stratified this annotation in three different ways: by locus, by
individual transcript, and by peptide (see sheets 1 through 3, respectively, of Supplemental Data set 1). As a result of our annotation,
we separated the 85 distinct peptides into three categories: 38 map to
protein-coding genes that overlap GENCODE v7 lncRNA transcripts
in the same orientation, 19 correspond to translatable lncRNA genes
that do not overlap a coding transcript, and 28 are untranslatable in
that they are located in-frame to, and downstream from, one or more
stop codons in exons of lncRNA transcripts. All but 10 of these peptides were observed only once (see Supplemental Data set 1).
Protein-coding genes constitute the most abundant class of
loci in this data set. In some cases, it is clear why the specific
GENCODE transcript was annotated as an lncRNA, as the transcript’s splicing was different from that of RefSeq isoforms of the
same gene. However, in all cases, the genomic mapping of the
peptide (see Methods) corresponds to a protein-coding exon
shared by a RefSeq isoform and the lncRNA. Because MS/MS data
provides only short peptides, not full-length protein sequences, we
were unable in any of these cases to prove that the peptide was
necessarily translated from the noncoding GENCODE transcript.
Hence, we do not consider peptides that match exons shared
by conventional coding and noncoding transcripts of the same
protein-coding gene to be evidence of the translation of the differently spliced lncRNA. This conservative position is supported by
the fact that 8 of 10 of the loci with shared coding exons give rise to
non-singleton peptides. This means that 80% of the lncRNAs in
our data set for which we have non-singleton peptides can be
explained by shared coding exons and, hence, by translation of the
canonical mRNA of the corresponding protein-coding gene.
We identified two lncRNA loci with non-singleton peptides
(Fig. 3), which we refer to as putative cryptic mRNAs. In both cases,
only one peptide per locus was discovered, and the peptide was
identified in only one cell and compartment type, although on
different runs of the machine (technical replication). The fact that
only a single peptide would be detectable for a particular protein
is not necessarily surprising; it may be that only one peptide is
detectable by a mass spectrometer due to the dependence of the
ENCODE protocol on enzymatic digestion (Rohrbough et al. 2006).
The peptide SSLSILSCCAVIFSQAR (Fig. 3A–C) from the K562
nuclear fraction was exonically matched to the same-orientation
GENCODE lncRNA transcript ENST00000454997.1. Encoded
by the +1 ORF of this transcript, the peptide was untranslatable,
owing to an in-frame upstream TAG and a lack of intervening start
codons. This transcript is a part of a much larger transcriptional
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Figure 3. Manual annotation of non-singleton peptides aligning to GENCODE lncRNA exons: case studies. (A–C ) An untranslatable non-singleton
peptide encoded downstream from an unprocessed pseudogene. (A) BL2SEQ TBLASTN peptide-to-lncRNA alignment. (B) NCBI ORF Finder view of the
translation containing this peptide and upstream stops. (C ) UCSC Genome Browser view of the peptide (red box). Direction is positive strand (data not
shown). (D–F ) An untranslatable non-singleton peptide encoded by a standalone lncRNA exon. (D) BL2SEQ TBLASTN peptide-to-lncRNA alignment. (E )
NCBI ORF Finder view of the translation containing this peptide and upstream stops. (F ) UCSC Genome Browser view of the peptide (red box) encoded on
the negative strand of the genome.

unit corresponding to the unprocessed non-protein-coding AFG3L2like pseudogene, AFG3L1P. However, the peptide-matching exon
is located downstream from the region containing the pseudogene’s homology with its parental gene. We confirmed the lack
of any matches to this peptide in human AFG3L2-family genes
by BLASTP. There are no other protein-coding genes on the
same (positive) genomic strand, in the region shown in the figure,
that could produce transcripts accounting for this peptide’s
translation.
The peptide CIPLAFQRASK from the GM12878 nuclear fraction (Fig. 3D–F) was exonically matched to the same-orientation
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GENCODE lncRNA transcript ENST00000434292.1. Mapping to
the +1 ORF of the lncRNA, this peptide was also untranslatable, as
the cystein TGC codon is immediately preceded by a TGA stop. The
peptide maps to the last exon of a standalone lncRNA gene with
extremely limited cDNA and EST support. The splice acceptor site
preceding the exon is conserved only in primates. Similarly to the
previous case, there are no protein-coding genes in this region
whose alternative or uncharacterized transcripts could account for
this peptide.
These two cases represent the only data points in the lncRNA–
proteogenomics intersection, where peptides matching bona fide

LncRNAs are rarely translated
lncRNAs rather than false GENCODE lncRNA annotations arising
from GENCODE errors, were detected more than once. The remaining peptides, 59 singletons, were comprised of 27 untranslatable lncRNA genes, 18 translatable lncRNA genes, and 24 matches
to overlapping protein-coding transcripts (Supplemental Data set
1). Figure 4, A–C highlights one of the 18 theoretically translatable
lncRNA genes associated with a singleton peptide. The peptide
TGLRSISQHLGERMR is clearly contained in-frame between an
ATG start codon and a TGA stop codon (Fig. 4B). The peptide is
entirely within exon 2 of the negative-strand GENCODE lncRNA
shown, and cannot belong to either of the protein-coding genes in
the locus as those genes are genomically on the positive strand.
Figure 4, D and E, on the other hand, pinpoints one of the 24
matches to overlapping protein-coding transcripts. These matches
are the result of rare GENCODE misannotations in release 7 (the
GENCODE release used for this and all other ENCODE companion
papers). Three in-frame translatable peptides (red, Fig. 4E) correspond to GENCODE transcripts that are given a GENCODE
lncRNA biotype, but that are, logically, uncharacterized proteincoding splice variants of the protein-coding gene EMG1 that were
missed by GENCODE’s automated biotype assignment approach.
These misannotations have been largely eliminated in subsequent releases of GENCODE.

Discussion
The integration of transcriptome and proteome data provides an
empirical route to validate existing annotations of specific transcripts as endowed with, or devoid of, protein-coding capacity.
Though mapping genomic loci against lncRNA sequences has
provided new insights, we understand that whole-genome proteogenomic mapping—the method by which the loci were
identified—has some limitations. Due to the target size, mapping
against the entire human genomic sequence decreased the sensitivity of identifications at a constant FDR. Also, we did not consider
peptides encoded by multiple exons across splice junctions, or
post-translationally modified (PTM) peptides, in the mapping
process. Approximately 25% of tryptic-digested peptides span
exon boundaries, so not including them in a search can miss
crucial identifications (Tanner et al. 2007; Castellana et al. 2008).
Nor did we consider known SNPs or RNA-editing events as mapped
by RNA-seq (Djebali et al. 2012). Though inclusion of trans-exons,
PTM, SNPs, and RNA-editing events would increase sensitivity, their
inclusion would also greatly increase the database size (>1000
times larger) and thereby decrease specificity. At present, searching
a database of this magnitude is not feasible. This motivated our
comprehensive manual annotation of the lncRNA hits. Because this analysis only utilized contiguous whole-genome sixframe translation, peptides that provide compelling evidence of
lncRNA translation in our results could not be explained by
splice junctions, SNPs, or RNA-editing events in protein-coding
transcripts.
However, we determined that 38 of the 85 peptides we detected map to lncRNAs that entirely contain well-known coding
ORFs, meaning that we have identified several misannotations
in GENCODE. This highlights the need for continued HAVANA
manual annotation. Our machine-learning approach enabled us to
extrapolate an upper bound on the fraction of translated lncRNAs,
and since that was around 8%, we conclude that the GENCODE
effort has already produced an over 90% accurate disaggregation
of coding from noncoding genes. Additional targeted proteomics
data, especially data at higher sensitivities in these and other hu-

man cell lines and tissues, will be necessary to fully vet future annotations of the human genome. While the machine-learning
approach predicts 8% of bona fide lncRNAs to be translated, our
manual annotation of this particular peptide data set only identified translation of ;0.4% of lncRNAs, including the few cases
where the lncRNAs were mRNAs misannotated by GENCODE.
Our model indicates that this discrepancy is a result of the depletion of low-abundance proteins in the mass spec data.
Our machine-learning approach also revealed a previously
unknown positive correlation between translation and polyA
Cytosol RNA. The marginal positive effect of increased polyA
Cytosol expression is actually greater than the marginal effect
of increased polyA+ Cytosol expression (Fig. 2). Indeed, polyA
Cytosol RNA level is the single most important covariate for
prediction, although there are minor differences between the two
cell lines that may be due to underlying differences in RNA processing and degradation efficiency. We note that K562 is a chronic
myeloid leukemia cell line, while GM12878 is a normal but EBVimmortalized LCL. We hypothesize that this fraction may be
measuring post-translational RNA processing, by which we mean
the degradation and metabolism of transcripts after translation,
resulting in polyA fragments localized in the cytosol. This illustrates the importance of considering the direction of causality
in statistically predictive models. Although the natural biological
temptation is to think of RNA levels as ‘‘causing’’ or ‘‘influencing’’
protein levels (and therefore peptide detectability) the opposite
may be true: Abundant proteins may be translated from highabundance transcripts with correspondingly abundant degradation products. That the presence of such degradation products, if
our hypothesis is correct, is a better indicator of translational
competence than the polyA+ Cytosol fraction remains an intriguing subject for future study. Future experiments should investigate whether these degraded polyA sequences, derived from
previously translated RNAs in the cytosol, are nonfunctional, or
whether they are stable due to post-cleavage 59-capping (Otsuka
et al. 2009) and may carry out additional roles in the cell,
attesting to multifunctionality and interrelatedness of long
and short RNAs.
We found two putative cryptic mRNAs in the GENCODE
manually annotated lncRNAs, and this observation coupled with
our machine-learning approach leads us to conclude that translations of cryptic mRNAs are rare in the proteome of the ENCODE
cell lines K562 and GM12878. Moreover, our confidence in these
two transcripts as cryptic mRNAs is tempered by the fact that
the matched peptides were preceded by upstream stop codons,
meaning that upstream splicing, ribosomal frameshifting, or RNA
editing, not captured in public cDNA/EST data from these loci,
would be necessary to explain the incidence and structure of any
translatable transcripts from either locus.
We did not observe any evidence of pervasive translation, i.e.,
a process conceptually analogous to the accepted paradigm of
pervasive transcription (Clark et al. 2011). This result stands
in contrast to the work of Ingolia et al. (2011) in mouse ES cells.
We note that MS/MS is dependent on the steady-state abundance
of proteins, whereas Ribo-seq measures the instantaneous rate
of translation, and tells us nothing about the longevity of any
resulting polypeptides. It could be that the majority of the ubiquitous translation identified in Ingolia et al. (2011) corresponds to
rapidly degraded molecules. Furthermore, high-throughput immunogenomic analysis of human peptides indicates that they
can function as novel autoantigens (Larman et al. 2011). Ectopic
lncRNAs may represent one source of ORFs giving rise to such
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Figure 4. Manual annotation of translatable peptides aligning to GENCODE lncRNA exons: case studies. (A–C ) A translatable singleton peptide
encoded at a bona fide lncRNA locus. (A) BL2SEQ TBLASTN peptide-to-lncRNA alignment. (B) NCBI ORF Finder view of the translation containing this
peptide (highlighted) including its furthest upstream ATG and its downstream stop (red rectangles). (C ) UCSC Genome Browser view of the peptide (red
box). Direction is negative strand. The singleton peptide is encoded by exon 2 of a GENCODE lncRNA that is divergently transcribed in the antisense
orientation relative to the known gene CACNA1G. (D,E ) A translatable non-singleton peptide traceable to a GENCODE misclassification of a protein-coding
transcript of the EMG1 gene that had been assigned an lncRNA biotype. (D) Three peptides (red) that are in-frame to the EMG1 known protein (full-length
shown) but are assigned to the GENCODE lncRNA ENST00000439543.2. (E ) UCSC Genome Browser view of the peptide (red box). Direction is positive
strand. The lncRNA is a noncoding transcript from the coding EMG1 locus. However, the peptides correspond to known coding exons of the EMG1 RefSeq,
not solely to exons of the noncoding transcript. (E1) Peptide matches the common coding mRNA exon, not a unique exon of the lncRNA (this is true in all
cases). (E2) GENCODE v7 lncRNA match.

autoantigenic peptides. Accordingly, disease specificity and immunogenicity of lncRNA-encoded peptides may warrant future
investigation, and may enhance ENCODE’s impact on clinical and
translational medicine. Since we already have MS/MS in these cell
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lines, conducting Ribo-seq on matched samples will be a priority
for future work.
In at least one case, we may have observed an example of
Gouldian exaptation (Brosius and Gould 1992): AFG3L1P is a

LncRNAs are rarely translated
transcribed pseudogene that appears translated. By manual annotation, we conclusively mapped a repeatedly detected peptide to
a novel downstream exon of the pseudogene transcriptional unit,
an exon beyond the 39end of the parental gene similarity region
and absent in the parental gene locus. Hence, this may represent
an instance of the exaptation of a transcribed pseudogene into
novel protein-coding function, distinct from the parental gene
(Fig. 3).
The vast majority of the peptides we detected were singletons
and, hence, likely correspond to either false positives or rare proteins (Greenbaum et al. 2003; Lu et al. 2007). A possible explanation for some of the singleton lncRNA-encoded peptides may be
the pioneer round of translation by ribosomes at the nuclear periphery. Many lncRNAs, including an abundant subset of endogenous antisense lncRNAs, are nuclear (Kiyosawa et al. 2005). Export of an lncRNA into the cytoplasm could subject it to the same
nonsense-mediated decay machinery as a mRNA. This machinery
entails ribosomal proofreading, with a pioneer round of translation by ribosomes located just outside of the nucleus, not Golgi/
ER. RNAs with multiple post-stop splice junctions are targeted for
degradation (Hwang et al. 2010). However, it may also be that
these proofreading transcripts are insufficiently abundant to be
detected by MS/MS. Another intriguing possibility is that we are
observing the outcomes of ribosomal frame shifting, RNA editing,
or splicing not yet identified by ENCODE or GENCODE. This
possibility is supported by the observation that many of our
singleton peptides are preceded by an in-frame upstream stop codon and lack an in-frame ATG codon. Of course, these may also
simply be false positives in the MS/MS data, and/or the products
of ectopic translation. Exploring these possibilities will be the topic
of future work.
This is the first study to empirically evaluate the translational
competence of human lncRNAs. An important caveat of proteogenomic interrogations of ENCODE cell line data sets is that
lncRNA translation may be different in vivo in organismal tissues,
and may be highly atypical (either suppressed or unusually frequent) in the two cancer cell lines that we studied here. Hence, we
expect that many additional tissues will be needed in order to
understand the protein-coding capacity of human transcripts. A
secondary concern is the incomplete nature of the GENCODE
lncRNA data set. Mining raw cDNA and EST data for lncRNA genes
lacking GENCODE counterparts should create a more inclusive
lncRNA reference data set for future proteogenomic studies of the
complete human lncRNAome. Mass spectrometric approaches
need to be substantially improved in order to accurately detect and
quantify peptide abundance from human tissue samples and primary cell cultures in addition to cancer cell lines.

Methods
Quantification of transcription rates at the level of whole genes
RNA-seq data was obtained from the ENCODE RNA Dashboard
(http://genome.crg.es/encode_RNA_dashboard/). Quantifications
for GENCODE v7 genes were derived using the Flux Capacitor algorithm (http://flux.sammeth.net/) and these quantities were
obtained from Supplemental Material in Djebali et al. (2012). In
total, we utilized gene-by-gene quantifications for biological replicates of samples GM12878: poly(A) Whole Cell, Cytosol, Nuclear;
and poly(A)+ Whole Cell, Cytosol, Nuclear; and K562: Total RNA
Nucleoplasm, Nucleolus, Chromatin; poly(A) Whole Cell, Cytosol, Nuclear; and poly(A)+ Whole Cell, Cytosol, Nuclear.

Proteomic analysis
We performed shotgun proteomic analyses for two ENCODE Tier1 cell
lines K562 and GM12878. Subcellular fractionation was performed
on both cell lines following a common protocol, producing four
fractions for each cell line: nuclear, mitochondrial, cytosolic, and
membrane fractions (Cox and Emili 2006). SDS-PAGE separation and
in-gel digestion was then performed as described by Shevchenko et al.
(2006). The collected protein fractions were further processed using
filter-aided sample preparation (FASP) (Wisniewski et al. 2009) or the
GOFAST method (Y Yu, L Xie, HP Gunawardena, J Khatun, C Maier,
M Leerkes, M Giddings, X Chen, in prep.). Tandem mass spectrometry data were produced using an LTQ Orbitrap Velos mass spectrometer (Thermo Scientific) (J Khatun, Y Yu, J Wrobel, BA Risk, HP
Gunawardena, A Secrest, WJ Spitzer, L Xie, L Wang, X Chen, et al., in
prep.). We obtained eight different sets of data, totaling 998,570
high-resolution MS/MS spectra. To perform proteogenomic mapping, we used two proteogenomic mapping software packages, Peppy
(http://geneffects.com/Peppy) and Genome Fingerprint Scanning
(GFS). HMM_Score was used in both programs to match and score
each MS/MS spectrum to the best-fit peptide sequence. A 6-frame
translation and proteolytic digestion of the whole human genome
(UCSC hg19, 2009) was used for proteogenomic mapping. See also
Supplemental Methods and Legends.

Integrating RNA-seq expression data with the proteogenomic
mappings—a machine learning approach
Machine learning was conducted using the RuleFit3 package
(Friedman and Popescu 2008; http://www-stat.stanford.edu/;jhf/
r-rulefit/rulefit3/R_RuleFit3.html). RuleFit3 classification models are
composed of several decision trees that make weighted contributions to the final classification rule applied to each observation. The
package was used in classification mode with the option tree.size=6,
and all other options at default values. We fit our predictors to distinguish between genes with at least one uniquely mapping peptide
and genes with none; however, using a threshold of two uniquely
mapping peptides did not qualitatively change any results. Due to
the sparsity of the MS/MS data, to increase the sensitivity of our
classifier, we sampled training sets such that 50% of observations
corresponded to RNAs with at least one peptide match observed in
the uniquely mapping peptide data, and the other 50% without any
uniquely mapping peptides. Predictions were then tested on heldout test data in the usual way. Additionally, the RuleFit3 package
gives the predicted values as a numeric score whose absolute value
reflects confidence that its sign is the same as that of the response.
We used a fivefold cross-validation to select the optimal cutoff for
these scores to further improve the error rates (maximizing the sum
of true positive and true negative classification rates).
We further validated the robustness of our classification
approach by fitting on one set of replicates of the RNA-seq experiments, and then validating on a held-out test set in a nonoverlapping collection of replicates. Because we do not have biological
replicates of the MS/MS data at this time, we could not adopt the
same approach with our response variable.

Obtaining plots of the relative importance of the RNA
fractions for predictive power
Variable importance (the contribution of each covariate to the
overall predictive power of the fitted model) is computed as in
Friedman and Popescu (2008), (with an overview in Gerstein et al.
2012). In general, the relative importance of a covariate quantifies
its usefulness for the prediction problem at hand. We assessed
the importance of each RNA fraction in both cell lines and in
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nonoverlapping collections of biological replicates. Only results that
were stable under both biological replication and between cell lines
were reported. The function ‘‘varimp’’ was used in its default settings
to produce the variable importance bar plots in Figure 2, A and B.

Assessing the interactions between RNA fractions
We assessed the statistical significance of pairwise covariate interactions using the RuleFit3 function ‘‘twovarint,’’ which utilizes a bootstrapped null interaction model to impute the usefulness of the covariates for prediction when only their marginal
distributions are known. This is described in detail in Friedman
and Popescu (2008). For statistically significant interactions, as
in Figure 2, we used the function ‘‘pairplot’’ to visualize the nature of the dependence of our classifications on pairs of covariates. That is, pairplot cannot be used to estimate the marginal
increase in likelihood of classification as a function of a small
increase in either covariate (that is beyond the capabilities of the
software), but it can provide a visualization of the nature of the
dependence of predictions on the covariates; hence, these plots
can be considered ‘‘scale free,’’ only the shape of the 2D curve is
relevant. For instance, a pairplot following the plane z = x + y
would indicate linear dependence on the covariates. In the current study, most dependencies are approximately monotonic,
but none are linear.

Estimating the total fraction of translated lncRNAs in K562
and GM12878—identifying mRNAs with expression patterns
similar to lncRNAs
The RuleFit3 approach utilizes a combination of linear models and
‘‘rules’’ to conduct classification and prediction. Rules are simply
decision trees. Hence, the program functions like a version of
Random Forests (Breiman 2001) with the addendum of recent
boosting, regularization, and dimension reduction techniques.
Although in principle the models that we fit could have included
linear terms, they did not, they included only decision trees. There
is also an option in the software ‘‘rulefit,’’ model.type=‘‘rules,’’
which we could have used to enforce this behavior. This is significant because it permitted us to take a Random Forests approach to
clustering. That is, as in Breiman(2001), we collected proteincoding genes that fell into the same terminal nodes in decision
trees as lncRNA genes. In particular, we defined the ‘‘signature’’ of
a gene to be a binary string encoding every terminal node into
which the gene fell in the fitted model. We called the expression
pattern of two genes ‘‘similar’’ when the binary strings were
identical. This clustered 90% of lncRNA genes, on average, with at
least one coding gene. A complete fitted rule set for each cell line
can be found in Supplemental Data File 2.
We also attempted to fit more standard regression models, such
as logistic regression, but the fit to the data was poor. For comprehensive details and additional Methods see Supplemental Data File 3.

Data access
Bed files for all proteogenomic mapping results uploaded to
the UCSC Data Coordination Center (DCC) can be accessed via
http://genome.ucsc.edu/cgi-bin/hgTrackUi?db=hg19&g=wgEncode
UncBsuProt. All proteomic data uploaded to Proteome Commons in
DTA format and their accession numbers are available in the Supplemental Material and at http://giddingslab.org/data/encode/
proteome-commons. Raw RNAseq reads can be accessed from the
NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.
nih.gov/geo/) under accession number GSE30567. Additional detailed methods for RNA sequencing can be obtained in the Production
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Documents under ‘‘CSHL Long RNA-seq’’ at http://genome.ucsc.
edu/ENCODE/downloads.html. The lncRNA annotations can be
found on the Guigo group website: http://big.crg.cat/bioinformatics_
and_genomics/lncrna. Finally, the GENCODE annotation is freely
available at http://www.gencodegenes.org. All data is accessible via
the ENCODE DCC at http://genome.ucsc.edu/ENCODE/. All code
developed for the analyses presented here can be found in Supplemental Data File 4.
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